Hospira’s Web Notice Discontinuing Execution Drug Has Global Implications - But Will Executions Stop? No: Meet Besse Medical of Ohio

more+
less-

On January 21, 2011, via its website, Illinois drug manufacturer Hospira, Inc. fired a shot heard ‘round the world as it announced in a short and sweet press release that it would no longer be making sodium thiopental (product name, Pentothal™). According to Hospira:

Hospira had intended to produce Pentothal at its Italian plant. ... [W]e cannot take the risk that we will be held liable by the Italian authorities if the product is diverted for use in capital punishment. Exposing our employees or facilities to liability is not a risk we are prepared to take.

Please see full article below for more information.

LOADING PDF: If there are any problems, click here to download the file.

Written by:

more+
less-

Terence Lenamon on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.
×
Loading...
×
×